Valuation: CARMAT

Market Cap 61.46L 69.97L 57.15L 52.45L 98.54L 67Cr 1Cr 6.79Cr 2.65Cr 33Cr 2.63Cr 2.57Cr 114.54Cr P/E 2023
-3.09x
P/E 2024 -0.95x
Enterprise Value 5.92Cr 6.75Cr 5.51Cr 5.06Cr 9.5Cr 649.6Cr 9.65Cr 65Cr 26Cr 319.37Cr 25Cr 25Cr 1.1TCr EV / Sales 2023
56.1x
EV / Sales 2024 13.5x
Free-Float
89.06%
Yield 2023 *
-
Yield 2024 -
Manager TitleAgeSince
Chief Executive Officer 55 01/09/2016
Director of Finance/CFO - 12/12/2018
Chief Tech/Sci/R&D Officer - 01/04/2025
Director TitleAgeSince
Director/Board Member 55 -
Director/Board Member 68 02/01/2017
Director/Board Member 79 20/04/2017
Change 5-day change 1-year change 3-year change Capi.($)
-50.96%-54.87% - - 70.8L
+3.54%+3.25%-18.16%+13.52% 13TCr
+1.92%-0.96%-2.85%-4.52% 1.28TCr
+0.95%-2.07%+62.86%+106.79% 901.61Cr
-6.12%-1.94%-48.53%-70.40% 438.94Cr
-0.21%-2.71%-1.65%+36.76% 262.55Cr
-2.59%-0.76%-20.35%-25.38% 158.84Cr
-3.05%-2.46%-27.45%-34.57% 157.87Cr
+3.72%-0.15%-1.85%-57.71% 155.59Cr
Average -5.87%-1.82%-7.25%-4.44% 2TCr
Weighted average by Cap. +2.81%+2.14%-12.89%+13.86%

Financials

2023 2024
Net sales 38.37L 43.69L 35.68L 32.74L 61.52L 42Cr 62.47L 4.24Cr 1.66Cr 21Cr 1.64Cr 1.6Cr 72Cr 73.44L 83.62L 68.3L 62.67L 1.18Cr 81Cr 1.2Cr 8.11Cr 3.17Cr 40Cr 3.14Cr 3.07Cr 136.88Cr
Net income -5.39Cr -6.13Cr -5.01Cr -4.6Cr -8.64Cr -590.65Cr -8.77Cr -59Cr -23Cr -290.38Cr -23Cr -23Cr -1TCr -5.14Cr -5.85Cr -4.78Cr -4.39Cr -8.24Cr -563.52Cr -8.37Cr -57Cr -22Cr -277.05Cr -22Cr -21Cr -957.89Cr
Net Debt 4.96Cr 5.65Cr 4.62Cr 4.24Cr 7.96Cr 544.23Cr 8.08Cr 55Cr 21Cr 267.56Cr 21Cr 21Cr 925.11Cr 5.31Cr 6.05Cr 4.94Cr 4.53Cr 8.51Cr 582.21Cr 8.65Cr 59Cr 23Cr 286.24Cr 23Cr 22Cr 989.67Cr
Logo CARMAT
Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.
Employees
153